• Chinese herbal medicine may be used as malaria treatment

Bioanalytical

Chinese herbal medicine may be used as malaria treatment

A Chinese herbal medicine could be used as treatment for Malaria, after work by scientists at the Scripps Research Institute investigated its properties.

Chang Sham has been used for thousands of years to treat fevers connected with malaria, and its benefits have now been uncovered thanks to a high-resolution structure solved by specialists at Scripps Research Institute.

As revealed in the journal Nature, the structure displays in atomic detail how a two-headed compound derived from the active ingredient in Chang Shan functions.

Before the work, experts were aware of the halofuginone compound's ability to suppress parts of the immune system, but nobody knew exactly how this was accomplished.

It has been found that the new structure operates like a wrench in the works, with halofuginone jamming the metaphorical gears of a molecular machine that carries out "aminocylation", a biological process that enables organisms to synthesize the proteins they require to live.

Professionals believe Chang Shan could help with malarial fevers because traces of a halofuginone-like chemical in the herb interfere with this same process in malaria parasites, destroying them in the bloodstream of infected people.

Halofuginone has been used in clinical trials for cancer, though the high-resolution picture of the molecule indicates it possesses a modularity that would make it useful with regard to the creation of new pharma drugs for other diseases.

Paul Schimmel, PhD, chair of Molecular Biology and Chemistry and member of The Skaggs Institute for Chemical Biology at TSRI, said "Our new results solved a mystery that has puzzled people about the mechanism of action of a medicine that has been used to treat fever from a malaria infection going back probably 2,000 years or more.

"This is a remarkable example where a substrate of an enzyme (ATP) captures an inhibitor of the same enzyme, so that you have an enzyme-substrate-inhibitor complex."

This work comes after the Florida campus of the Scripps Research Institute developed technology to change the function of RNA in living cells.

The team created a new approach to design molecules which recognise and disable RNA targets.

Posted by Fiona Griffiths


Digital Edition

Chromatography Today - Buyers' Guide 2022

October 2023

In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions

Events

SCM-11

Jan 20 2025 Amsterdam, Netherlands

Medlab Middle East

Feb 03 2025 Dubai, UAE

China Lab 2025

Feb 05 2025 Guangzhou, China

PITTCON 2025

Mar 01 2025 Boston, MA, USA

H2 Forum

Mar 04 2025 Berlin, Germany

View all events